Staccato Alprazolam: 12 Clinical Trials, Page 1 of 2

1 2 »

Hide Studies Not Open or Pending

A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

Condition(s):Stereotypical Prolonged SeizuresLast Updated:February 3, 2023Enrolling by invitation

A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

Condition(s):Stereotypical Prolonged SeizuresLast Updated:February 3, 2023Recruiting

A Relative Bioavailability Study of Staccato Alprazolam Versus Oral Alprazolam in Healthy Study Participants

Condition(s):Healthy ParticipantsLast Updated:January 27, 2023Recruiting

Study to Assess the Safety, Tolerability, And Pharmacokinetics of Staccato Alprazolam in Healthy Japanese, Chinese, and Caucasian Participants

Condition(s):Healthy Study ParticipantsLast Updated:May 17, 2021Completed

A Study to Assess the Pharmacokinetics (PK) and Safety of Staccato Alprazolam in Adolescent Study Participants With Epilepsy

Condition(s):EpilepsyLast Updated:June 30, 2022Completed

Pharmacokinetic Study Evaluating Staccato^® Alprazolam 1 mg Inhaler in Smokers Versus Non-Smokers

Condition(s):HealthyLast Updated:April 7, 2022Completed

A Study to Assess the Pulmonary Safety of Staccato Alprazolam in Healthy Study Participants and in Study Participants With Mild Asthma

Condition(s):Healthy Study Participants; Participants With Mild AsthmaLast Updated:December 5, 2022Completed

Staccato Alprazolam in Panic Attack

Condition(s):Treatment of Induced Panic AttackLast Updated:June 16, 2017Completed

Staccato Alprazolam Abuse Liability

Condition(s):Abuse Liability of Staccato AlprazolamLast Updated:January 2, 2020Completed

Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern

Condition(s):EpilepsyLast Updated:February 3, 2021Completed